SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020056
Filing Date
2023-05-10
Accepted
2023-05-10 06:51:04
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q reta-20230331.htm   iXBRL 10-Q 1685065
2 EX-10.1 reta-ex10_1.htm EX-10 38305
3 EX-10.2 reta-ex10_2.htm EX-10 2323764
4 EX-10.3 reta-ex10_3.htm EX-10 470376
5 EX-31.1 reta-ex31_1.htm EX-31 22143
6 EX-31.2 reta-ex31_2.htm EX-31 22466
7 EX-32.1 reta-ex32_1.htm EX-32 13068
8 EX-32.2 reta-ex32_2.htm EX-32 13159
9 GRAPHIC img71891053_0.jpg GRAPHIC 26219
  Complete submission text file 0000950170-23-020056.txt   8893234

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT reta-20230331_def.xml EX-101.DEF 150937
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT reta-20230331_lab.xml EX-101.LAB 361949
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT reta-20230331.xsd EX-101.SCH 46981
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT reta-20230331_cal.xml EX-101.CAL 37219
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT reta-20230331_pre.xml EX-101.PRE 252560
60 EXTRACTED XBRL INSTANCE DOCUMENT reta-20230331_htm.xml XML 809905
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 23904254
SIC: 2834 Pharmaceutical Preparations